Internal Medicine, Cardiovascular Disease · Hamilton, NJ
NPI
1154309532
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2073 Klockner Rd
Hamilton, NJ, 08690
Phone (609) 584-1212
Groups this clinician bills Medicare through
Medicare paid, 2024
$577K
11,759 services
Medicare patients, 2024
1,222
Average age 76
Drug cost, 2024
$2.7M
13,080 prescriptions
Company payments, 2025
$649
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ronald G Ryder was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 1,809 times for 856 patients. In total Ronald G Ryder billed 11,759 services in 30 codes, and Medicare paid $577K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-01-28.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,809 | 856 | $12.85 | $23K |
| 99214 Office E&M - Established | Office | 1,749 | 857 | $96.71 | $169K |
| 99454 E&M - Miscellaneous | Office | 1,736 | 200 | $40.42 | $70K |
| 93000 Electrocardiogram | Office | 1,348 | 811 | $11.11 | $15K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,338 | 147 | $52.06 | $70K |
| 99457 E&M - Miscellaneous | Office | 920 | 195 | $40.70 | $37K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 722 | 97 | $40.35 | $29K |
| 99458 E&M - Miscellaneous | Office | 629 | 102 | $32.68 | $21K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 336 | 84 | $4.66 | $1,567 |
| 93015 Electrocardiogram | Office | 186 | 184 | $52.20 | $9,710 |
| 99215 Office E&M - Established | Office | 172 | 148 | $143.01 | $25K |
| 93306 Echocardiography (TTE/TEE) | Office | 162 | 161 | $155.91 | $25K |
| 78452 Myocardial Perfusion Scan | Office | 123 | 123 | $364.29 | $45K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 123 | 122 | $90.85 | $11K |
| 99233 Hospital E&M - Subsequent | Facility | 117 | 64 | $97.27 | $11K |
By year: 2022 $741K for 11,658 services; 2023 $568K for 9,622 services; 2024 $577K for 11,759 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ronald G Ryder prescribed most often to Medicare patients was Metoprolol Succinate, with 1,490 prescriptions and refills. In total Ronald G Ryder wrote 13,080 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 1,490 | 4,205 | 454 | $24K |
| Atorvastatin Calcium Generic | 1,309 | 3,741 | 401 | $15K |
| Rosuvastatin Calcium Generic | 1,070 | 3,046 | 322 | $16K |
| Xarelto Rivaroxaban | 908 | 2,004 | 226 | $1.1M |
| Amlodipine Besylate Generic | 882 | 2,495 | 297 | $6,415 |
| Ezetimibe Generic | 490 | 1,405 | 145 | $12K |
| Clopidogrel Clopidogrel Bisulfate | 451 | 1,248 | 145 | $6,636 |
| Amlodipine-Olmesartan Amlodipine Bes/Olmesartan Med | 384 | 1,027 | 118 | $20K |
| Eliquis Apixaban | 372 | 776 | 91 | $432K |
| Olmesartan Medoxomil Generic | 306 | 860 | 101 | $7,494 |
| Icosapent Ethyl Generic | 286 | 704 | 99 | $131K |
| Bumetanide Generic | 282 | 658 | 131 | $6,787 |
| Valsartan Generic | 255 | 702 | 78 | $12K |
| Carvedilol Generic | 244 | 642 | 79 | $2,203 |
| Metoprolol Tartrate Generic | 242 | 684 | 80 | $2,320 |
Brand drugs: 2,126 claims; generic drugs: 10,954 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ronald G Ryder $649 ($649 in general payments such as food, travel and fees) from 12 companies. The largest payer was Boston Scientific Corporation with $201.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 10 | $201 |
| Amgen Inc. AMGN | 6 | $106 |
| Novo Nordisk Inc NVO | 4 | $80.96 |
| BridgeBio Pharma, Inc. BBIO | 4 | $66.78 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $37.73 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $34.11 |
| Actelion Pharmaceuticals US, Inc. JNJ | 2 | $32.94 |
| Impulse Dynamics (USA) Inc. | 1 | $24.58 |
| Pfizer Inc. PFE | 1 | $17.24 |
| Edwards Lifesciences Corporation EW | 1 | $17.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.